- Kilitch Drugs (India) Ltd
- KILITCH (NSE)
Kilitch Drugs (India) Limited is an India-based company, which is engaged in the development and operations of pharmaceutical business. It is primarily engaged in the development, manufacturing, and marketing of finished dosages. The Company’s products include parenteral solutions, effervescent, nutritional products, and medical device. Its products categories include urinary alkalizer, cephalosporins products, gastroenterology, non steroidal anti-inflammatory drugs (NSAIDs), anticonvulsant/antiepileptic, adrenergic agonist, neurotonic, muscle relaxant/stimulant, aminoglycosides, anti-infective, anti-inflammatory, anti-malarials, anti-hypertensive, anaesthetic, uterine stimulants. Its parenteral solutions include neurotonic, veterinary products, metered nasal drops, vaccines, oncology, and ophthalmic products. Its effervescent products include Roipar, Duregra, And Roivit. The Company offers nutritional products, such as Celtine. The Company also offers medical devices, such as C-Seal.
Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.